Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026)

Prothena Corp Public's (PRTA) quarterly Depreciation & Amortization (CF) came in at $184000.0 in Q1 2026, down 17.49% year-on-year from $223000.0 in Q1 2025, and down 15.6% quarter-over-quarter from $218000.0 in Q4 2025.

Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Prothena Corp Public's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $184000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 17.49% year-over-year to $184000.0 in Q1 2026; TTM through Mar 2026 was $856000.0, a 4.99% decrease from a year earlier, with the FY2025 full-year figure at $895000.0, changed 0.22% from the prior year.
  • Depreciation & Amortization (CF) slipped to $184000.0 in Q1 2026 per PRTA's latest filing, from $218000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $276000.0 in Q4 2023 and bottomed at $182000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $221000.0 (2024), against an average of $214352.9.
  • Across the five-year window, Depreciation & Amortization (CF) tumbled 40.13% in 2022 and jumped 40.82% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $196000.0 in 2022, then soared by 40.82% to $276000.0 in 2023, then slipped by 19.93% to $221000.0 in 2024, then dropped by 1.36% to $218000.0 in 2025, then slipped by 15.6% to $184000.0 in 2026.
  • Per Business Quant, the three latest PRTA Depreciation & Amortization (CF) figures stand at $184000.0 (Q1 2026), $218000.0 (Q4 2025), and $229000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 184,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 184,000.00
Mar 31, 2026 184,000.00
Dec 31, 2025 218,000.00
Dec 31, 2025 218,000.00
Sep 30, 2025 229,000.00
Sep 30, 2025 229,000.00
Jun 30, 2025 225,000.00
Jun 30, 2025 225,000.00
Mar 31, 2025 223,000.00
Mar 31, 2025 223,000.00
Dec 31, 2024 221,000.00
Dec 31, 2024 221,000.00
Sep 30, 2024 226,000.00
Sep 30, 2024 226,000.00
Jun 30, 2024 231,000.00
Jun 30, 2024 231,000.00
Mar 31, 2024 215,000.00
Mar 31, 2024 215,000.00
Dec 31, 2023 276,000.00
Dec 31, 2023 276,000.00